How much funding has Mirum Pharmaceuticals raised?

Mirum Pharmaceuticals has raised $188.5M in total funding, most recently a Private Equity round.

Who are Mirum Pharmaceuticals's investors?

Mirum Pharmaceuticals's investors include TCG Crossover, New Enterprise Associates, Deerfield Management, Frazier Healthcare, Novo Holdings A/S, Pappas Capital.

When was Mirum Pharmaceuticals founded?

Mirum Pharmaceuticals was founded in 2018.

Where is Mirum Pharmaceuticals headquartered?

Mirum Pharmaceuticals is headquartered in Foster City, California, United States.

What industry is Mirum Pharmaceuticals in?

Mirum Pharmaceuticals operates in Biotech, Healthcare, Therapeutics.

How many employees does Mirum Pharmaceuticals have?

Mirum Pharmaceuticals has 201-500 employees.

Mirum Pharmaceuticals

IPO

Home - Mirum Pharma

Public · Foster City, United States · Founded 2018 · $188.5M raised

Biotech

Healthcare

Therapeutics

Headquarters: Foster City, California
Employees: 201–500
Founded: 2018
Business Model: B2B
Website: mirumpharma.com

Total Funding: $188.5M
Last Round: $68.5M Private EquityDec 2025
Rounds: 2
Type: Public

About

Mirum Pharmaceuticals is a high-growth rare disease biopharmaceutical company focused on advancing medicines for cholestatic liver diseases. Founded in 2018 in Foster City, California, the company commercializes LIVMARLI (maralixibat), approved for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis, and is advancing volixibat, an IBAT inhibitor in late-stage development for primary sclerosing cholangitis and additional cholestatic conditions.

Summary

Mirum Pharmaceuticals is a Biotech company based in Foster City, United States, founded in 2018. It has raised $188.5M in total across 2 rounds, most recently a $68.5M Private Equity round in Dec 2025. Investors include TCG Crossover, New Enterprise Associates and Deerfield Management.

LinkedIn X (Twitter)